Projects

Nanovex Biotechnologies SL  performs R&D internal projects to improve, innovate or expand our portfolio of products and services.

In addition, our company participates and collaborates with other companies, universities and research centers in R&D projects carried out both by public funding, through calls for national and international organizations, and private funding.

Some of the projects funded by public organizations in which Nanovex Biotechnologies participates or has participated:

  • Design and development of new nanomaterial-based products for use in bioassays and flow citometry
  • Adaptation of the process to obtain new products based on nanomaterials
  • Integración de un sistema de microalgas, extracción y nanoencapsulación de compuestos de alto valor añadido para producir productos cárnicos saludables

COLLABORATION OFFER FOR HORIZON 2020 CALLS

2018 – 2020

Nanovex Biotechnologies SL is a Spanish SME specialized in the design&development of nanovesicles, nanocapsules and inorganic nanoparticles for multiple applications. The company participates in various national and international research & innovation projects. Company is opened to offer their expertise for the Horizon2020 calls 2018 – 2020, presented on the following table.

Contact information info@nanovexbiotech.com

PROJECT DEADLINE TOPIC EXPERTISE OFFERED
NMBP-22-2018 23/01/2018

Pre-proposal

Osteoarticular tissues regeneration (RIA) Bioactive compound encapsulation in polymeric nanocapsules to improve the tissue regeneration
TRANSCAN2

 

6 february 2018

Pre-proposal

Rare Tumors Nanoencapsulation,

Theranostic delivery systems,

Extracellular Vesicles detection, drug delivery systems

SC1-BHC-15-2018 6 february 2018

Pre-proposal

New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID) Bioconjugated nanovesicles and metallic nanoparticles, drug delivery systems, diagnostics
SC1-BHC-09-2018 18 April 2018 Innovation platforms for advanced therapies of the future Magnetic Nanoparticles,

Bioconjugation techniques

ERA PerMed

 

April 2018

Pre-proposal

Personalised Medicine- Preclincal research Drug encapsulation; new theranostic systems, Customized nanoparticles development

COMPANY INFORMATIONS

Organisation: Nanovex Biotechnologies SL

Location: Parque Tecnológico de Asturias (SPAIN)

Website: www.nanovexbiotech.com

Institutional status: Medium-sized enterprise (SME)

Area of activities: Provider of nanobiotechnological products and services for academia and industry

Título del proyecto: “ PLAN DE INTERNACIONALIZACIÓN”

Expediente: IDE/2017/000188

Título del proyecto: “ PLAN DE PROMOCIÓN Y COMERCIALIZACIÓN DE LOS PRODUCTOS PRONANOSOME Y NANOPARTÍCULAS METÁLICAS”

Expediente: IDE/2016/000278

Project: “Novel magnetic nanostructures for medical applications”

Acronym: MAGNAMED

File number: 734801

Brief description and objectives: Development of novel magnetic nanostructures for the treatment of various diseases

This project has been approved by the European Commission

Título del proyecto: “Diseño, desarrollo y validación de un instrumento microfluídico integrado para la generación de nanovesículas.”

Expediente: SNEO-20151097

Título del proyecto: “ Desarrollo y puesta a punto de nuevos productos basados en nanomateriales para su empleo en bioensayos ELISA y citometría de flujo.

Expediente: IDE/2014/000707

Ayuda para la contratación de un titulado superior 

Título del proyecto: “DISEÑO Y DESARROLLO DE NANOVESÍCULAS PARA EL AUMENTO DE LA SENSIBILIDAD EN LOS SITEMAS DE DETECCIÓN DE ENFERMEDADES

Expediente: ITE-16-002